RETROSPECTIVE STUDY OF CULTURAL SENSITIVITY PATTERN OF URINE FOR PAST ONE YEAR IN IMRAN IDREES TEACHING HOSPITAL LAB
DOI:
https://doi.org/10.60127/sjms.4.4.2026.99Keywords:
E.Coli, Klebsiella, Pseudomonas, Proteus, Meropenem, Imipenem, AmikacinAbstract
Objectives: To assess the Cultural sensitivity pattern of urine for the year of 2024 in IITH lab.
Methods: A retrospective study was carried out on registered patients presented in IITH during the year 01-01-2024 to 31-12-2024.
Results: Out of 181 samples (83 males, 98 females), 60 (33%) were culture positive. The most common isolates were E. coli (43%) and Klebsiella (40%), followed by Pseudomonas, Proteus, and a few others in low frequency. Antibiotic sensitivity patterns showed high effectiveness of Meropenem (91.2%) and Imipenem (90%), followed by Amikacin (74.5%) and Gentamycin (73.3%). In contrast, high resistance was noted against fluoroquinolones (Ciprofloxacin, Levofloxacin, Norfloxacin) and Co-trimoxazole, making them less reliable treatment options.
Conclusion: This highlights the predominance of E. coli and Klebsiella in infections and the rising concern of multidrug resistance, with carbapenems remaining the most effective agents.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Muhammad Kaleem, Jawad Saeed, Huraira Irfan, Hussain Shahid, Mudassir Razzaq, Mughees Khalid, Usama, Muneeb Haider, Zain Azhar (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright to their work and grant the Sial Journal of Medical Sciences the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.

